<HashMap><database>biostudies-literature</database><scores/><additional><submitter>Hao W</submitter><funding>Priority Academic Program Development of Jiangsu Higher Education Institutions</funding><funding>National Natural Science Foundation of China</funding><funding>Higher Education Discipline Innovation Project</funding><funding>Natural Science Foundation of Jiangsu Province</funding><pagination>14395-14409</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC9749471</full_dataset_link><repository>biostudies-literature</repository><omics_type>Unknown</omics_type><volume>13(48)</volume><pubmed_abstract>The functionally evolved bacterial chassis is of great importance to manufacture a group of assorted high value-added chemicals, from small molecules to biologically active macromolecules. However, the current evolution frameworks are less efficienct in generating &lt;i>in vivo&lt;/i> genomic diversification because of insufficient tunability, rendering limited evolution spacing for chassis. Here, an engineered genomic diversification platform (CRISPR-ABE8e-CDA-nCas9) leveraging a programmable dual-deaminases base editor was fabricated for rapidly evolving bacterial chassis. The dual-base editor was constructed by reprogramming the CRISPR array, nCas9, and cytidine and adenosine deaminase, enabling single or multiple base conversion at the genomic scale by simultaneous C-to-T and A-to-G conversion &lt;i>in vivo&lt;/i>. Employing titration of the Cas-deaminase fusion protein, the platform enabled editing any pre-defined genomic loci with tunable conversion efficiency and editable window, generating a repertoire of mutants with highly diversified genomic sequences. Leveraging the genomic diversification platform, we successfully evolved the nisin-resistant capability of &lt;i>Bacillus subtilis&lt;/i> through directed evolution of the subunit of lantibiotic ATP-binding cassette. Therefore, our work provides a portable and programmable genomic diversification platform, which is promising to expedite the fabrication of high-performance and robust bacterial chassis used in the development of biomanufacturing and biopharmaceuticals.</pubmed_abstract><journal>Chemical science</journal><pubmed_title>Construction and application of an efficient dual-base editing platform for &lt;i>Bacillus subtilis&lt;/i> evolution employing programmable base conversion.</pubmed_title><pmcid>PMC9749471</pmcid><funding_grant_id>111-2-06</funding_grant_id><funding_grant_id>21878125</funding_grant_id><funding_grant_id>32171420</funding_grant_id><funding_grant_id>BK20181206</funding_grant_id><pubmed_authors>Han L</pubmed_authors><pubmed_authors>Cui W</pubmed_authors><pubmed_authors>Hao W</pubmed_authors><pubmed_authors>Suo F</pubmed_authors><pubmed_authors>Cheng Z</pubmed_authors><pubmed_authors>Zhou Z</pubmed_authors></additional><is_claimable>false</is_claimable><name>Construction and application of an efficient dual-base editing platform for &lt;i>Bacillus subtilis&lt;/i> evolution employing programmable base conversion.</name><description>The functionally evolved bacterial chassis is of great importance to manufacture a group of assorted high value-added chemicals, from small molecules to biologically active macromolecules. However, the current evolution frameworks are less efficienct in generating &lt;i>in vivo&lt;/i> genomic diversification because of insufficient tunability, rendering limited evolution spacing for chassis. Here, an engineered genomic diversification platform (CRISPR-ABE8e-CDA-nCas9) leveraging a programmable dual-deaminases base editor was fabricated for rapidly evolving bacterial chassis. The dual-base editor was constructed by reprogramming the CRISPR array, nCas9, and cytidine and adenosine deaminase, enabling single or multiple base conversion at the genomic scale by simultaneous C-to-T and A-to-G conversion &lt;i>in vivo&lt;/i>. Employing titration of the Cas-deaminase fusion protein, the platform enabled editing any pre-defined genomic loci with tunable conversion efficiency and editable window, generating a repertoire of mutants with highly diversified genomic sequences. Leveraging the genomic diversification platform, we successfully evolved the nisin-resistant capability of &lt;i>Bacillus subtilis&lt;/i> through directed evolution of the subunit of lantibiotic ATP-binding cassette. Therefore, our work provides a portable and programmable genomic diversification platform, which is promising to expedite the fabrication of high-performance and robust bacterial chassis used in the development of biomanufacturing and biopharmaceuticals.</description><dates><release>2022-01-01T00:00:00Z</release><publication>2022 Dec</publication><modification>2026-05-27T23:03:22.435Z</modification><creation>2024-11-10T03:45:09.651Z</creation></dates><accession>S-EPMC9749471</accession><cross_references><pubmed>36545152</pubmed><doi>10.1039/d2sc05824c</doi></cross_references></HashMap>